#India Diagnostic Labs Market | Explore Tumblr Posts and Blogs

athenese-dx · 5 months

Text

Celebrating 10 Years' Journey of Athenese-Dx Pvt. Ltd.

celebration #10years #athenesedx #Chennai #IVD #India #milestone

🎉 Celebrate a Decade of Innovation with Athenese-Dx! Join us in our 10th Anniversary Celebration as we continue to honor a decade of groundbreaking achievements at Athenese-Dx. This special video takes you on a journey through our most memorable moments, showcasing our commitment to excellence and innovation.

Highlights:

Milestone Moments: Relive our top achievements and how they've shaped the industry. From pioneering diagnostic technologies to life-changing breakthroughs, we've been at the forefront of medical advancements.Behind-the-Scenes: Get an exclusive look at the people and passion driving our success. Meet our brilliant scientists, dedicated researchers, and tireless support staff who have fueled our journey.Future Forward: Peek into the future as we unveil exciting plans for the next decade. Discover our vision for improving patient care, expanding global reach, and revolutionizing healthcare.

Thank You to Our Community: We extend our heartfelt gratitude to our customers, partners, and employees who have been part of our story. Your unwavering support and trust have propelled us forward.

Stay Connected: Don't miss out on any updates as we embark on the next chapter of our journey

diagnosticcenter #rapidtest #elisakit #biochemistry #ivdmanufacturing #clinicalchemistry #ivdinstrument #medicaldevices #reagents

Together, let's continue to redefine diagnostics and transform lives. Here's to the next ten years of excellence! 🥂 🎉 Cheers to many more amazing years! 🎉

ATHENESE-DX PRIVATE LIMITED Address: Module No. 407 & 408, 4th Floor, TICEL Bio Park II, No. 5, CSIR Road, Taramani, Chennai, Tamil Nadu - 600113, India

For Inquires - WhatsApp +917397238924 Click here to chat: https://wa.me/917397238924

For Reviews & News, go to https://www.athenesedx.com/

🌎 Visit our office - https://qr.page/g/5lZXERbP8Av

🤝 Subscribe - https://youtube.com/@athenesedx Our early diagnosis products for a better life. Thank you for your support.

🔔 For more videos, products, reviews ↷ YouTube ▶ https://youtube.com/@athenesedx

🌐 For more information ↷ Website ▶ https://athenesedx.com To Buy Athenese-Dx Products ▶ https://store.athenesedx.com

📱 Follow us on social media ↷ Facebook ▶ https://www.facebook.com/Athenese.Dx.Pvt.Ltd/ Instagram ▶ https://www.instagram.com/athenese_dx/ Pinterest ▶ https://www.pinterest.com/athenesedx/ X (Twitter) ▶ https://twitter.com/athenesedx Tumblr ▶ https://www.tumblr.com/athenese-dx LinkedIn ▶ https://www.linkedin.com/company/athenese-dx-private-limited/ Medium ▶ https://medium.com/@athenesedx01

0 notes

rohit890 · 2 years

Text

Clinical Trial Imaging Market 5.9% CAGR Projection Over The Next Five Years

Market Overview

Clinical Trial Imaging is the use of imaging modalities, analysis services, and software to ascertain the effectiveness of innovative drugs before they are made available for purchase. Clinical imaging methods are being utilised more frequently in oncology treatment trials to demonstrate the efficacy and safety of the drug. Positron Emission Tomography (PET), Optical Coherence Tomography (OCT), Magnetic Resonance Imaging (MRI), and Ultrasound are the imaging technologies most frequently employed in clinical trials. During the projection period, the market is anticipated to be driven by the rise in cancer diagnoses and deaths globally. However, it is anticipated that the industry's growth prospects will be constrained by the severe government regulations in the field.

View Detailed Report Description: https://www.globalinsightservices.com/reports/clinical-trial-imaging-market/

Market Dynamics

The most important aspect, like an increase in R&D expenditures, is an increase in R&D expenditures. Companies in the pharmaceutical and biotechnology industries spend a lot of money on research to create novel compounds. The market for clinical trial imaging is predicted to grow as a result of rising government and pharmaceutical R&D spending as well as a growing emphasis on life science projects to create new therapeutic and diagnostic products. Similarly, developing nations like India, South Korea, Brazil, and Mexico present substantial potential opportunities to market participants in clinical trial imaging, primarily as a result of the rising R&D investment in these nations.

A notable trend in these emerging markets is the commercialization of life science research. These economies are expected to present the clinical trial imaging market with substantial growth prospects due to considerable advancements in life sciences research. Additionally, there are other CROs that provide drug development services to pharmaceutical and biotechnology businesses in Asian markets, particularly China and India. The need for clinical trial imaging is predicted to rise in emerging nations in the next years due to the large increase in R&D spending and CROs operating in these nations.

The key players in the global clinical trial imaging market are ICON plc. (Ireland), BioTelemetry Inc. (US), Biomedical Systems Corporation (US), Medpace Holdings, Inc. (US), IXICO plc. (UK), Resonance Health Ltd. (Australia), Radiant Sage LLC. (US), BioClinica Inc. (US), Intrinsic Imaging LLC. (US), Cardiovascular Imaging Technologies LLC. (US), Medical Metrics Inc. (US), Prism Clinical Imaging, Inc. (US), Boston Imaging Core Lab LLC. (US), anagram 4 clinical trials (Spain), Lyscaut Medical Imaging Company (Belgium), Calyx Group (UK), Bioseptive Inc. (Canada), ProScan Imaging LLC. (US), Micron Inc. (Japan), Imaging Endpoints LI, LLC (US), Perspectum Ltd. (UK), Pharmtrace Klinische Entwicklung GmbH (Germany), WorldCare Clinical, LLC (US).

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Global Insight Services LLC

16192, Coastal Highway, Lewes DE 19958

E-mail: [email protected]

Phone: +1–833–761–1700

2 notes · View notes

gdgoenka6 · 2 days

Text

Best Paramedical Institutes in Bhilwara: Building a Bright Future in Healthcare

In recent times, the healthcare business has seen an increase in the need for highly skilled professionals with high levels of knowledge. With the constant advancements in medical technology and the growing demand for healthcare professionals, paramedical education has become an important area. Paramedics provide the backbone of healthcare, providing vital assistance to doctors, nurses, and their patients throughout a variety of medical conditions. Therefore, selecting the field of paramedical sciences isn't just rewarding but also extremely desired.

Bhilwara is an internationally well-known city situated in Rajasthan, quickly becoming a major player in the field of health education. With many well-established and best Paramedical Institutes in Bhilwara offers aspiring healthcare professionals the opportunity to receive the highest quality of training and establish a successful profession. This article will examine the best paramedical colleges in Bhilwara that are shaping our future of healthcare professionals.

Why Choose Paramedical Education?

Before looking at the most prestigious medical institutions located in Bhilwara, It is essential to comprehend why training in paramedicine is necessary. Paramedical professionals are proficient in providing medical assistance in the event of an emergency, diagnosing processes, and other health procedures. They are radiography technicians, medical laboratory specialists, Emergency Medical specialists (EMTs), operating theater technicians, and physical therapists as indifferent.

Paramedical professionals collaborate with doctors and nurses to ensure the smooth running of hospitals and diagnostic centers. As healthcare facilities expand and change, the need for trained paramedics is increasing, and the demand for paramedical education is growing in the job market today.

Paramedical Institutes: A Gateway to Success

Bhilwara has witnessed an increased number of students attracted to paramedical training programs. In order to meet the growing demand, several institutes have been created as reliable centers that provide top-quality healthcare instruction. They focus on giving students hands-on training in addition to equipping them with the required skills needed to be successful in the health field.

Let's look at some of the highly regarded paramedical colleges in Bhilwara and discover the factors that make their institutions unique.

GD Goenka Healthcare Academy

GD Goenka Healthcare Academy is a well-known brand in the field of health education and provides many of the best paramedical programs across India. It is known for its high academic excellence and excellent infrastructure. The institution has earned itself a high-profile reputation by providing high-quality healthcare education and preparing highly qualified professionals who are capable of meeting the requirements of the medical field.

At the GD Goenka Healthcare Academy, students can take advantage of a wide range of certificate and diploma programs, which include radiography and medical laboratory technology, as well as operating theater and emergency medical technologies. The academy's modern laboratories, the most up-to-date methods of instruction, and partnerships with the top hospitals will ensure that students receive the best quality instruction using hands-on techniques.

The main advantage of GD Goenka is its faculty, which is made up of professionals with decades of experience who offer an abundance of academic expertise as well as practical knowledge in classes. Students are instructed through rigorous programs that prepare them for actual medical situations that arise, which makes GD Goenka one of the top Paramedical Institutes in Bhilwara and all over.

Bhilwara Medical Academy

Bhilwara Medical Academy is another famous institute that has gained fame in the field of paramedicine. The academy offers many diploma programs, such as medical laboratory technology, radiography, and emergencies. The school believes in the importance of learning acquired through the experience of others. Students receive on-the-job instruction at the best hospitals in Rajasthan.

With a dedicated faculty and an ardent commitment to educating the next generation of medical professionals, Bhilwara Medical Academy remains one of the top choices for students who want the best medical schools for paramedical students within Bhilwara.

Sunshine Paramedical Institute

Sunshine Paramedical Institute prides itself on its commitment to student-centeredness, providing individual guidance and assistance to every pupil. The school offers a variety of paramedical programs that span from physical therapy and medical lab technology to ensure that students select an option that is compatible with their professional objectives.

The focus of the school is on education in the field. This, along with regularly interacting with professionals in the field, aids students in achieving success in their careers. Sunshine Paramedical Institute is widely recognized as one of the top Paramedical colleges in Bhilwara, especially for its dedication to ensuring the best quality of health education.

Global Paramedical Training Center

Global Paramedical Training Center is a highly regarded institute located in Bhilwara that provides a wide range of paramedical courses, including optometry, anesthesia, and cardiac treatment. The center puts a great deal of emphasis on the significance of innovation in the field of health education and incorporates the latest technologies and techniques in its teaching.

With highly trained faculty members and an extensive array of hospitals with opportunities for placement, the Global Paramedical Training Center gives a solid foundation to students to excel at the highest level of health care. Global Paramedical Training Center has gained its place among the paramedical colleges in Bhilwara by providing a full learning experience.

Building a Future in Healthcare

Paramedical science isn't only about job security; it enables professionals to make a significant impact on society by providing the highest-quality medical care. Bhilwara is one of the most highly regarded paramedical colleges, and it offers students the opportunity to build the foundations of this vital field.

The mentioned institutes are well-known for their commitment to offering high-quality training with hands-on instruction, as well as extensive medical courses. If you're looking to become a lab technician, EMT, or radiographer, Bhilwara provides many opportunities to reach your goals and land the most of your career in the field of health healthcare.

Conclusion

The best paramedical college could be the initial step toward a lucrative career in the healthcare field. With a number of top Paramedical Institutes in Bhilwara, those interested in the field have access to the best facilities, along with education and training opportunities across the region. These institutions are dedicated to forming our future healthcare professionals by providing them with the skills and knowledge required to be successful in the rapidly evolving sector.

Suppose you decide to pursue a degree in paramedicine through an accredited school. In that case, you are not only obtaining your position but also contributing to the benefit of society through the integral component of medical treatment.

#best Paramedical Institutes in Bhilwara #top Paramedical Institutes in Bhilwara #Paramedical Institutes in Bhilwara

0 notes

ankitab · 6 days

Text

Exploring the Sample Preparation Market: Applications, Key Players, and Market Outlook

The Sample Preparation Market is projected to reach $12.77 billion by 2031, growing at a CAGR of 6.4% from 2024 to 2031. This growth is driven by advancements in sample preparation procedures, increased automation in laboratories, the establishment of bio-clusters to support research, rising R&D investments in the pharmaceutical and biotechnology sectors, and active research in genomics and proteomics.

Download free sample report here: https://www.meticulousresearch.com/download-sample-report/cp_id=5527?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=19-09-2024

Furthermore, the expanding applications of sample preparation in emerging economies and the increased focus on personalized medicine present significant market growth opportunities.

Sample Preparation Market Growth Drivers

Technological Advances in Sample Preparation Procedures

Advancements in sample preparation techniques have led to increased efficiency and accuracy. These improvements include integrating multiple steps into a single chip for point-of-care devices, miniaturizing extraction techniques, and developing automated systems. Automation enhances sample processing speed, reduces errors, increases safety for lab technicians, and improves customization and optimization for research protocols. Miniaturized extraction techniques, which use less organic solvents and reagents, require smaller sample amounts, simplify procedures, and offer high enrichment factors, are also gaining traction.

Increasing R&D Investments

Pharmaceutical companies are heavily investing in R&D and expanding manufacturing facilities to meet market demand. According to the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), R&D investments in the U.S. and Europe have grown significantly. In the U.S., venture capital investment in biotechnology firms for R&D increased from $11 billion in 2015 to $15 billion in 2020. Similarly, R&D activities in the food and beverage industry, aimed at developing products with higher nutritional value and longer shelf life, are driving the demand for sample preparation products and software.

Browse in depth : https://www.meticulousresearch.com/product/sample-preparation-market-5527?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=19-09-2024

Sample Preparation Market Opportunity

Widening Applications in Emerging Economies

Emerging economies like China, Japan, and India are making significant investments in R&D across various industries, including biotechnology, pharmaceuticals, food and beverages, and environmental sciences. Robust sample preparation techniques are essential for these studies. Additionally, advances in healthcare infrastructure in countries like India and China, including the development of new diagnostic laboratories, hospitals, and clinics, are driving the demand for sample preparation procedures.

Sample Preparation Market Analysis: Key Findings

By Product: Consumables Segment to Dominate in 2024

The sample preparation market is segmented into consumables, instruments, workstations, and software. In 2024, the consumables segment is expected to hold the largest share at 50.8%. This growth is driven by new product launches, increased use of analytical techniques, and the frequent usage of isolation, extraction, and purification kits for nucleic acids and proteins.

By Technique: Solid Phase Extraction (SPE) Segment to Dominate in 2024

The market is segmented into Solid Phase Extraction (SPE), Liquid Phase Extraction (LPE), filtration, dilution, precipitation, and other techniques. In 2024, the SPE segment is expected to hold the largest share due to advancements in automated and miniaturized devices and its widespread use in various industries such as pharmaceuticals, environmental analysis, food and beverage, clinical diagnostics, and forensic sciences.

By Application: Drug Discovery Segment to Dominate in 2024

The market is segmented into drug discovery, diagnostics, genomic studies, proteomic studies, analytical testing, and other applications. In 2024, the drug discovery segment is expected to hold the largest share due to high R&D expenditure in the pharmaceutical industry, the prevalence of non-infectious and infectious diseases, and increasing collaborations between research institutes and pharmaceutical companies

Sample Preparation Market: Key Companies

The competitive landscape includes key market players such as Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Illumina, Inc. (U.S.), Merck KGaA (Germany), Hamilton Company (U.S.), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc. (U.S.), Tecan Group Ltd. (Switzerland), Promega Corporation (U.S.), and Norgen Biotek Corp. (Canada). The top 4-5 players hold approximately 53-58% of the global market share.

Quick buy: https://www.meticulousresearch.com/Checkout/98565808?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=19-09-2024

Contact Us: Meticulous Research® Email- [email protected] Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

0 notes

tmr-blogs2 · 7 days

Text

Recombinant Chemicals Market Overview: Expanding at a 7.8% CAGR by 2034

Recombinant chemicals are produced using recombinant DNA technology, where organisms like bacteria, yeast, or mammalian cells are genetically engineered to produce specific chemicals. These products are widely used in various industries, including pharmaceuticals, biotechnology, agriculture, and environmental services, offering improved efficiency, sustainability, and customization over traditional chemical production methods.

The demand for recombinant chemicals has surged due to their ability to create high-purity products with lower environmental impact. These chemicals are critical in drug development, diagnostic testing, and agricultural biotechnology, among other applications. With the growing focus on environmental sustainability and the development of personalized medicine, the recombinant chemicals market is expected to experience significant growth during the forecast period.

Market Size and Growth

The global recombinant chemicals industry, valued at US$ 2.9 billion in 2023, is projected to grow at a CAGR of 7.8% from 2024 to 2034, reaching US$ 6.7 billion by the end of 2034.This growth is driven by increasing demand for biotechnological advancements, the rise of green chemistry, and expanding applications in sectors such as healthcare, food production, and industrial biotechnology.

For More Details, Request for a Sample of this Research Report: https://www.transparencymarketresearch.com/recombinant-chemicals-market.html

Market Segmentation

The recombinant chemicals market is segmented based on various factors such as service type, sourcing type, application, industry vertical, and region.

By Service Type:

Production Services: Encompassing custom chemical production and contract manufacturing.

Research and Development Services: Services aimed at developing novel recombinant chemicals for different industries.

By Sourcing Type:

In-house Production: Recombinant chemicals produced within organizations using proprietary techniques.

Outsourced Production: Companies outsourcing production to contract manufacturers or third-party labs.

By Application:

Pharmaceuticals and Biotechnology: Used in drug development, therapeutic proteins, and vaccines.

Agriculture: For genetically modified crops and biopesticides.

Food and Beverages: Enzymes for food processing.

Industrial Biotechnology: Chemicals for bio-based production of industrial products.

By Industry Vertical:

Healthcare

Agriculture

Environmental Biotechnology

Food and Beverages

Energy

Industrial Manufacturing

By Region:

North America

Europe

Asia-Pacific

Latin America

Middle East & Africa

Regional Analysis

North America: Dominates the recombinant chemicals market due to the presence of leading biotechnology firms and advanced healthcare infrastructure. The U.S. and Canada are key markets, driven by significant investments in research and development (R&D) and a robust regulatory framework that encourages innovation.

Europe: Europe ranks second, with Germany, the UK, and France leading the region. Strong government support for biotechnology research and a growing emphasis on sustainable chemical production are key growth drivers.

Asia-Pacific: The fastest-growing region due to expanding pharmaceutical and biotechnology industries in countries like China, India, and Japan. The region benefits from cost-effective production, large talent pools, and increasing adoption of advanced biotechnology in agriculture and healthcare.

Latin America and the Middle East & Africa: These regions are expected to witness moderate growth due to increasing investments in biotechnology infrastructure and growing demand for bio-based products.

Market Drivers and Challenges

Market Drivers:

Growing Demand for Biopharmaceuticals: Recombinant chemicals are widely used in drug discovery and production, with increasing demand for therapeutic proteins, vaccines, and personalized medicines driving market growth.

Environmental Sustainability: Recombinant chemicals offer a more sustainable alternative to traditional chemical synthesis, reducing the environmental impact and waste associated with chemical production.

Technological Advancements: Innovations in genetic engineering and bioprocessing technologies are making recombinant chemical production more efficient and scalable.

Challenges:

High Production Costs: The production of recombinant chemicals involves complex processes and advanced technologies, which can drive up costs, limiting the market's accessibility, particularly in developing economies.

Regulatory Hurdles: Strict regulatory frameworks for genetically modified organisms (GMOs) and recombinant chemicals can slow market growth, especially in countries with stringent regulations.

Market Trends

Rise of Green Chemistry: Increasing focus on sustainable and eco-friendly solutions is pushing the recombinant chemicals market toward green chemistry, where biotechnology is used to develop bio-based and biodegradable chemicals.

Advancements in Genetic Engineering: Continuous improvements in gene editing tools like CRISPR are enabling more precise and efficient production of recombinant chemicals, leading to higher-quality products and expanded applications.

Integration with Artificial Intelligence (AI): AI-driven drug discovery and process optimization are increasingly being integrated into recombinant chemical production, improving efficiency and reducing time-to-market for new products.

Future Outlook

The recombinant chemicals market is set for transformative growth over the next decade. Increasing investment in biotechnology, growing awareness of environmental sustainability, and expanding applications across various industries will drive the market forward. However, addressing challenges such as production costs and regulatory complexities will be essential for maintaining sustainable growth.

The pharmaceutical and biotechnology sectors will remain major growth contributors, especially with the ongoing development of biopharmaceuticals and personalized medicine. The agriculture sector is also expected to witness significant advancements as genetically modified crops and bio-based fertilizers become more prevalent.

Key Market Study Points

Assessing the impact of technological advancements in genetic engineering on recombinant chemical production.

Evaluating the role of government policies and funding in supporting market growth.

Analyzing the competitive landscape, including key market players and their strategic initiatives.

Understanding consumer demand for sustainable and eco-friendly chemicals across industries.

Buy this Premium Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=86368&ltype=S

Competitive Landscape

Key players in the recombinant chemicals market include Merck KGaA, Thermo Fisher Scientific, Lonza Group, GenScript Biotech, and Agilent Technologies. These companies are investing heavily in R&D to expand their product portfolios and improve production efficiencies. Strategic partnerships, acquisitions, and collaborations with biotech firms are common strategies to strengthen market positioning.

Recent Developments

July 2024: Merck KGaA announced a partnership with a leading biotech firm to develop next-generation recombinant enzymes for industrial applications.

August 2024: Thermo Fisher Scientific expanded its recombinant protein production facilities in Asia-Pacific to cater to the growing demand in the region.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.

CORPORATE HEADQUARTER DOWNTOWN,

1000 N. West Street,

Suite 1200, Wilmington, Delaware 19801 USA

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com

0 notes

isocertificationinegypt · 8 days

Text

ISO 15189 Certification in Bangalore: Ensuring Excellence in Medical Laboratories

ISO 15189 Certification in Bangalore is an international standard specifically developed for medical laboratories to establish quality and competence in lab services. This certification is designed to ensure that medical laboratories deliver accurate and reliable results while adhering to global standards for quality management and technical competence. In Bangalore, known for its advanced healthcare sector and growing medical infrastructure, ISO 15189 certification is becoming increasingly important for laboratories that want to enhance their service quality and gain trust among healthcare providers and patients.

The Importance of ISO 15189 Certification for Medical Laboratories in Bangalore

Bangalore is home to a rapidly growing healthcare industry, with numerous hospitals, diagnostic centers, and medical research facilities. As the city continues to advance in healthcare technologies and patient care, the demand for reliable medical testing has increased significantly. ISO 15189 certification ensures that medical laboratories in Bangalore adhere to stringent standards in both management and technical processes, resulting in improved diagnostic accuracy and overall service quality.

Laboratories that obtain ISO 15189 Certification in Bangalore demonstrate their commitment to continuous improvement, patient safety, and quality control. The certification helps laboratories not only meet international benchmarks but also comply with local regulations, ultimately improving public health outcomes by providing high-quality diagnostics.

Key Benefits of ISO 15189 Certification for Medical Laboratories

Improved Diagnostic Accuracy: ISO 15189 certification requires laboratories to maintain high standards of technical competence, ensuring that their test results are accurate and reliable. This is essential in Bangalore, where medical decisions based on lab results directly impact patient care and treatment outcomes.

Enhanced Patient Trust: With increasing competition in the healthcare sector, patient trust is crucial. Laboratories that are ISO 15189 certified are perceived as more credible, as this certification signals that they meet globally accepted quality and safety standards. Patients and healthcare providers in Bangalore are more likely to choose labs that demonstrate a commitment to quality.

Operational Efficiency: Implementing ISO 15189 standards leads to streamlined operations, as laboratories adopt systematic procedures for managing equipment, staff training, and workflow processes. This results in fewer errors, reduced re-testing, and faster turnaround times for lab results, all of which are critical in the fast-paced medical environment of Bangalore.

Regulatory Compliance: ISO 15189 Certification in Bangalore helps laboratories in Bangalore comply with national and international regulations. Many healthcare accreditation bodies in India and around the world recognize ISO 15189, making it easier for certified labs to meet local legal requirements while also gaining international recognition.

Increased Competitiveness: With the healthcare market in Bangalore becoming increasingly competitive, ISO 15189 certification can provide a competitive edge. Certified laboratories are more likely to attract partnerships with hospitals, clinics, and healthcare providers who seek high-quality lab services.

Steps to Achieving ISO 15189 Certification in Bangalore

Gap Analysis: The first step for any medical laboratory aiming for ISO 15189 certification is to conduct a gap analysis. This involves evaluating current processes, procedures, and technologies to identify areas that do not meet the ISO 15189 requirements.

Developing a Quality Management System (QMS): ISO 15189 places significant emphasis on having an effective QMS. Laboratories must develop and implement policies that address various aspects of lab management, including quality assurance, staff training, equipment maintenance, and data management.

Staff Training and Competency: Ensuring that all laboratory personnel are adequately trained is a critical component of ISO 15189 Certification in Bangalore. The standard requires that employees are not only knowledgeable in laboratory practices but also competent in using specialized equipment and adhering to safety protocols.

Internal Audits and Corrective Actions: Before undergoing an external certification audit, labs must conduct internal audits to identify any non-conformities. Corrective actions should be taken to address these gaps, ensuring full compliance with ISO 15189 standards.

External Certification Audit: Once the lab is prepared, an accredited certification body will conduct a thorough audit to verify compliance with ISO 15189. Upon successful completion, the lab will receive ISO 15189 certification.

#ISO 15189 Consultants in Bangalore #ISO 15189 in Bangalore #ISO 15189 Cost in Bangalore

0 notes

tamanna31 · 9 days

Text

Blood Screening Market 2023- Business Planning Research and Resources, Revenue, and Forecasts 2030

Blood Screening Market Size & Trends

The global blood screening market size was valued at USD 2.76 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 11.7% from 2023 to 2030.

Blood screening is a process in which donated blood is screened for infectious diseases such as HBV, HCV, HIV1, and HIV2. The high growth of this market is attributed to rising blood donations, an increase in the incidence of infectious diseases, and government initiatives. According to World Health Organization (WHO), 118.54 million blood donations are collected yearly. In the U.S., 6.8 million individuals donate blood annually, and 13.6 million units of red blood cells and whole blood are collected annually.

Gather more insights about the market drivers, restrains and growth of the Blood Screening Market

The market is primarily driven by the rise in the rate of disorders such as HIV, diphtheria, measles and chronic diseases such as hemophilia, cancer, and other blood-related disorders. Blood-based diagnostics are used to diagnose a wide range of diseases, including infectious diseases, cancer, and cardiovascular diseases. Serology tests detect the presence of antibodies to a specific disease-causing organism. These tests diagnose various infectious diseases, including HIV, hepatitis B, and syphilis. Molecular tests detect the presence of DNA or RNA from a specific disease-causing organism. These tests are more sensitive than serology tests and can be used to diagnose diseases at an earlier stage. Biochemical tests measure the levels of certain substances in the blood. These tests can diagnose a wide range of diseases, including diabetes, kidney disease, and liver disease.

The COVID-19 pandemic had a significant impact on the market. Although respiratory droplets are the primary means of COVID-19 virus transmission, research has shown that viral RNA may be discovered in blood samples, supporting blood screening for COVID-19 identification, hence driving the market significantly.

Blood Screening Market Segmentation

Grand View Research has segmented the global blood screening market based on technology, product, and region:

Technology Outlook (Revenue, USD Million, 2018 - 2030)

Nucleic Acid Amplification Test (NAT)

ELISA

Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)

Next Generation Sequencing

Western Blotting

Product Outlook (Revenue, USD Million, 2018 - 2030)

Reagent

Instrument

Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

Canada

Europe

Germany

France

Italy

Spain

Sweden

Norway

Denmark

Asia Pacific

Japan

China

India

Australia

Thailand

South Korea

Latin America

Brazil

Mexico

Argentina

Middle East and Africa

Saudi Arabia

South Africa

UAE

Kuwait

Browse through Grand View Research's Medical Devices Industry Research Reports.

The global embolic protection devices market size was valued at USD 612.9 million in 2023 and is projected to grow at a CAGR of 8.7% from 2024 to 2030.

The global covered stent market size was estimated at USD 1.13 billion in 2023 and is projected to grow at a CAGR of 4.1% from 2024 to 2030.

Key Companies & Market Share Insights

Product launches, approvals, strategic acquisitions, and innovations are just a few of the important business strategies used by market participants to maintain and grow their global reach.

For instance, in March 2023, Abbott received U.S Food and Drug Administration (FDA) clearance for a laboratory traumatic brain injury blood test, the first commercially available lab-based test for the assessment of mild traumatic brain injuries (TBIs), commonly referred to as concussions, which will be made widely available to hospitals across the U.S. This test, which is powered by Abbott’s Alinity i laboratory tool, will enable clinicians to evaluate individuals with mild traumatic brain injuries in a timely manner.

Furthermore, in May 2023, Siemens Healthcare introduced Atellica HEMA 570 and 580 next-generation hematology analyzers, which have user-friendly interfaces and can be connected to multiple analyzers to remove workflow barriers and provide high throughput time.

Key Blood Screening Companies:

Abbott

Danaher Corporation (Beckman Coulter)

Becton Dickinson and Company

Bio-Rad Laboratories, Inc.

Hoffman-La Roche Ltd.

Grifols, S.A.

Ortho-Clinical Diagnostics, Inc.

Siemens Healthcare GmbH

Thermo Fisher Scientific, Inc.

SOFINA s.a (Biomerieux)

Order a free sample PDF of the Blood Screening Market Intelligence Study, published by Grand View Research.

#Blood Screening Market

0 notes

creativeera · 13 days

Text

DNA and RNA Sample Preparation Market is Estimated to Witness High Growth Owing to Increasing Adoption

The DNA and RNA sample preparation market involves processes associated with isolation, extraction, purification and quantification of nucleic acids DNA and RNA from various sources like tissues, blood, sperm, cells etc. for downstream applications in genomics, molecular diagnostics, personalized medicine and others. The sample preparation is a critical and initial step before conducting various genomic tests including Next Generation Sequencing, polymerase chain reaction and other assays. Growing awareness and adoption of precision medicine and genetic/molecular testing is driving demand for efficient nucleic acid isolation and downstream analysis.

The Global DNA and RNA Sample Preparation Market is estimated to be valued at US$ 2262.46 Mn in 2024 and is expected to exhibit a CAGR of 5.8% over the forecast period 2024 To 2031. Key Takeaways Key players operating in the DNA and RNA sample preparation are Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., DiaSorin S.p.A, F. Hoffmann-La Roche, Miroculus, Inc., Illumina, Inc., PerkinElmer, Inc., QIAGEN, Sigma Aldrich Corp., Tecan Group AG, and Thermo Fisher Scientific, Inc. Growing prominence of personalized medicine is creating opportunities for development of new sample preparation methods and kits which can extract nucleic acids from various types of samples. Rising incidence of chronic and infectious diseases worldwide is increasing diagnostic testing which will propel sample preparation market growth. Global expansion of key market players through acquisitions and partnerships with regional diagnostic labs and research institutes will further augment market revenues. Market Drivers Increasing funding for Genomic and genetic research from government bodies as well as private sector is one of the key factors driving the DNA and RNA Sample Preparation Market Size. Government initiatives aimed at large scale population screening and clinical testing for various genetic disorders, infectious diseases and cancers are also creating demand for high throughput nucleic acid preparation. Growing geriatric population and rising healthcare spending in developing nations also provides growth opportunities for market players in the forecast period.

PEST Analysis Political: Laws and regulations imposed by governments for research using DNA and RNA samples could impact the market. Changes in healthcare policies will also have effects. Economic: Factors like GDP growth, income levels, healthcare spending will drive demand. Rise in research activities and focus on precision medicine boost the market. Social: Growing awareness about personalized medicine and importance of genetic testing are important. Social trends also promote preventive healthcare and wellness. Technological: Advancements in fields like next generation sequencing, lab automation, bioinformatics are key for market growth. Miniaturization and portability of equipment expand applications. Developments in sample collection and storage methods improve efficiency. Geographical regions where the market in terms of value is concentrated include North America and Europe. North America accounts for the largest share in the global market due to presence of well-established healthcare industry and research institutes. Europe also captures notable share due to growing biotech sector and research funding. The Asia Pacific region is projected to be the fastest growing market during the forecast period. This is attributed to factors such as increasing healthcare expenditure, growing awareness, expanding biotech industry and rising government investments in research. Countries like China, India offer growth opportunities as they focus on healthcare infrastructure development.

Get more insights on DNA And RNA Sample Preparation Market

Also read related article on Surgical Robots Market

Discover the Report for More Insights, Tailored to Your Language

French

German

Italian

Russian

Japanese

Chinese

Korean

Portuguese

Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.

(LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)

#Coherent Market Insights #DNA And RNA Sample Preparation Market #DNA And RNA Sample Preparation #RNA Sample Preparation #Nucleic Acid Extraction #Genetic Material Isolation #DNA Extraction #RNA Extraction #Molecular Biology #Genomic DNA

0 notes

shubhampawrainfinium · 15 days

Text

The Science of Safety: How Food Testing Ensures Quality and Health

The global food safety testing market is on a significant growth trajectory, fueled by increasing consumer awareness and regulatory requirements. According to the report, the market is projected to grow at a compound annual growth rate (CAGR) of 8.06% over the forecast period of 2022-2028. With a revenue of approximately USD 19 billion in 2022, the market is expected to reach approximately USD 30 billion by 2028.

Why Food Safety Testing Matters

Food safety testing is crucial for ensuring that food products are safe for consumption and meet regulatory standards. This process involves the detection and analysis of contaminants, pathogens, allergens, and other harmful substances in food products. Effective food safety testing helps prevent foodborne illnesses, protect consumer health, and ensure compliance with food safety regulations.

Get Sample pages of Report: https://www.infiniumglobalresearch.com/reports/sample-request/238

Market Dynamics and Growth Drivers

Several factors are driving the growth of the global food safety testing market:

Rising Foodborne Illnesses: The increasing incidence of foodborne illnesses and outbreaks is driving the demand for comprehensive food safety testing. Consumers and regulatory bodies are placing greater emphasis on ensuring the safety and quality of food products.

Stringent Regulatory Standards: Governments and regulatory agencies worldwide are implementing stricter food safety regulations and standards. These regulations require food manufacturers and processors to conduct regular testing to ensure compliance and protect public health.

Growing Consumer Awareness: Consumers are becoming more aware of food safety issues and are demanding higher standards of food quality and safety. This heightened awareness is driving the adoption of advanced testing methods to ensure the safety of food products.

Technological Advancements: Innovations in testing technologies, such as rapid testing methods, molecular diagnostics, and advanced analytical techniques, are enhancing the accuracy and efficiency of food safety testing. These advancements are expanding the capabilities of testing labs and improving the reliability of results.

Regional Analysis

North America: The North American market is characterized by stringent food safety regulations and high consumer awareness. The U.S. and Canada have established comprehensive food safety testing frameworks, driving market growth.

Europe: Europe is a major market for food safety testing, with a strong focus on regulatory compliance and consumer protection. Countries such as Germany, France, and the U.K. have implemented rigorous food safety standards, contributing to market expansion.

Asia-Pacific: The Asia-Pacific region is experiencing rapid growth in the food safety testing market due to increasing food production, rising consumer awareness, and expanding regulatory frameworks. Emerging economies like China and India are key contributors to market growth.

Latin America and Middle East & Africa: These regions are witnessing gradual growth in the food safety testing market, driven by increasing regulatory initiatives and growing consumer demand for safe food products. Market growth is supported by the implementation of food safety standards and regulations.

Report Overview : https://www.infiniumglobalresearch.com/reports/global-food-safety-testing-market

Competitive Landscape

The food safety testing market is competitive, with several key players and emerging companies offering a range of testing solutions. Notable players in the market include:

SGS SA: A global leader in inspection, verification, testing, and certification services, offering comprehensive food safety testing solutions.

Eurofins Scientific: Provides a wide range of food testing services, including microbiological, chemical, and allergen testing.

Intertek Group plc: Offers food safety and quality testing services, including laboratory testing and certification.

Bureau Veritas: Specializes in food safety testing and certification, focusing on regulatory compliance and consumer protection.

ALS Limited: Provides food safety testing services, including environmental and microbiological testing for food products.

Challenges and Opportunities

The food safety testing market faces challenges such as high testing costs, the need for continuous innovation, and the complexity of regulatory compliance. Additionally, ensuring the accuracy and reliability of testing methods can be challenging.

However, there are significant opportunities for growth. The increasing demand for advanced testing technologies, the expansion of regulatory frameworks, and the rising focus on consumer health present avenues for market expansion. Companies that invest in innovation, technological advancements, and strategic partnerships are well-positioned to capitalize on the growing demand for food safety testing.

Conclusion

The global food safety testing market is set for substantial growth, driven by rising foodborne illnesses, stringent regulatory standards, and growing consumer awareness. With revenue expected to reach approximately USD 30 billion by 2028, the market presents significant opportunities for investment and innovation. As the focus on food safety continues to intensify, food safety testing will play a critical role in ensuring the safety and quality of food products.

0 notes

industrynewsupdates · 29 days

Text

Blood Screening Market Analysis, Opportunities And Forecast Report 2024-2030

The global blood screening market size was valued at USD 2.76 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 11.7% from 2023 to 2030.

Gather more insights about the market drivers, restrains and growth of the Blood Screening Market

Blood Screening Market Segmentation

Grand View Research has segmented the global blood screening market based on technology, product, and region:

Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Nucleic Acid Amplification Test (NAT)

• ELISA

• Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)

• Next Generation Sequencing

• Western Blotting

Product Outlook (Revenue, USD Million, 2018 - 2030)

• Reagent

• Instrument

Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

o U.S.

o Canada

• Europe

o UK

o Germany

o France

o Italy

o Spain

o Sweden

o Norway

o Denmark

• Asia Pacific

o Japan

o China

o India

o Australia

o Thailand

o South Korea

• Latin America

o Brazil

o Mexico

o Argentina

• Middle East and Africa

o Saudi Arabia

o South Africa

o UAE

o Kuwait

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global embolic protection devices market size was valued at USD 612.9 million in 2023 and is projected to grow at a CAGR of 8.7% from 2024 to 2030.

• The global covered stent market size was estimated at USD 1.13 billion in 2023 and is projected to grow at a CAGR of 4.1% from 2024 to 2030.

Key Companies & Market Share Insights

Product launches, approvals, strategic acquisitions, and innovations are just a few of the important business strategies used by market participants to maintain and grow their global reach.

Key Blood Screening Companies:

• Abbott

• Danaher Corporation (Beckman Coulter)

• Becton Dickinson and Company

• Bio-Rad Laboratories, Inc.

• Hoffman-La Roche Ltd.

• Grifols, S.A.

• Ortho-Clinical Diagnostics, Inc.

• Siemens Healthcare GmbH

• Thermo Fisher Scientific, Inc.

• SOFINA s.a (Biomerieux)

Order a free sample PDF of the Blood Screening Market Intelligence Study, published by Grand View Research.

#Blood Screening Market #Blood Screening Industry #Blood Screening Market size #Blood Screening Market share #Blood Screening Market analysis

0 notes

varshamedblogs · 29 days

Text

The Future of Teleradiology in India: Growth and Trends

The future of teleradiology in India is poised for remarkable growth, driven by technological advancements and increasing demand for accessible healthcare. Teleradiology enables the remote transmission and interpretation of diagnostic images, making it a vital tool for enhancing healthcare delivery, especially in rural areas.

Impact on Indian Healthcare

Teleradiology is transforming healthcare in India by bridging the gap between patients in remote areas and specialized radiologists. This technology reduces the need for patients to travel long distances for diagnostic services, ensuring timely and accurate diagnoses.

It also alleviates the burden on urban healthcare centers by distributing workloads more evenly. As India faces a shortage of radiologists, teleradiology will play a crucial role in optimizing resource allocation and improving access to quality radiology services.

Current State and Market Growth

Teleradiology in India is rapidly expanding, with a projected growth rate of 18.6% CAGR from 2022 to 2027. Companies like Radisky Labs, Aster Medical Imaging, and Telerad Tech are leading the market, offering innovative diagnostic solutions. The increasing adoption of teleradiology is fueled by technological advancements, improved digital infrastructure, and supportive government policies.

#Teleradiology in India #career in radiology #advanced medical courses after MBBS

0 notes

trendingreportz · 30 days

Text

Clinical Oncology Next Generation Sequencing Market - Forecast(2024 - 2030)

Clinical Oncology Next Generation Sequencing Market Overview

Clinical Oncology Next Generation Sequencing Market size was valued at $1.4 billion in 2020 and projected to grow at a CAGR of 13.6% during the forecast period 2021-2026. Next-generation sequencing is a technique that helps to simultaneously perform multiple reactions from which it is possible to sequence DNA or RNA. Biological sciences have been revolutionized by massively parallel sequencing technologies i.e. next-generation sequencing (NGS). Targeted sequencing and re-sequencing provides advantages such as high throughput and lower cost per sample of the process thereby enhancing its application Companion Diagnostics. It is a method of assessing the nucleotide sequence in a DNA section and is used for oncology research and enables researchers to carry out a wide range of applications and study biological systems with their ultra-high throughput, scalability, and speed at a level never before possible. In addition, sequencing of the next generation helps in the evaluation of several genes in a single assay, thus reducing the need to order numerous tests to evaluate the underlying mutation thereby driving the Clinical Oncology Next Generation Sequencing Market. In tumour science, a high implementation rate in whole-genome sequencing (WGS) has been seen in recent years driving the Clinical Oncology Next Generation Sequencing Market Industry. The emergence of next-generation sequencing clinical applications in precision oncology has accelerated key company’s efforts to create new platforms that can be used for genomic assays. In February 2021, for instance, Congenica partnered with Gabriel Precision Oncology Ltd. to create an automatic software interface for clinical oncology interpretation using biotechnology. In routine clinical practice, this product will promote NGS-based molecular diagnostics of tumours.

Report Coverage

The report: “Clinical Oncology Next Generation Sequencing Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Clinical Oncology Next Generation Sequencing Market.

By Technology Type: Whole Genome Sequencing, Whole Exome Sequencing and Targeted Sequencing & Resequencing Centrifuges.

By Application: Screening - Sporadic Cancer and Inherited Cancer, Companion Diagnostics and Other Diagnostics.

By Workflow: NGS Pre-Sequencing, NGS Sequencing and NGS Data Analysis.

By End Use: Hospitals/Clinics, Laboratories and Research Labs.

By Geography: North America (U.S, Canada and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia & New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina and Rest of South America) and RoW (Middle East and Africa).

Request Sample

Key Takeaways

The increasing need for successful treatment of various cancer types and scientific developments in immunology, molecular biology and genetics are likely to contribute to the growth of the Clinical Oncology Next Generation Sequencing industry.

Geographically, North America Clinical Oncology Next Generation Sequencing Market held the largest revenue share of 36% in 2020 owing to an increased emphasis on cancer treatment by government agencies, a rise in healthcare spending and the presence of sufficient resources in the healthcare industry in this region.

The growth of the market is driven by rising research and development activities using NGS technologies, growing NGS applications in clinical diagnosis and discovery applications that demand NGS technology.

Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market is provided in the Clinical Oncology Next Generation Sequencing Market.

Clinical Oncology Next Generation Sequencing Market Segment Analysis - By Technology Type

Based on Technology Type, Clinical Oncology Next Generation Sequencing Market is segmented into Whole Genome Sequencing, Whole Exome Sequencing and Targeted Sequencing & Resequencing Centrifuges. Targeted Sequencing & Resequencing Centrifuges accounted for the largest revenue market share in 2020 help reduce the expense, time, and volume of data analysed during tumour sample sequencing which is anticipated to favourably impact the segment growth. Targeted sequencing uses deep sequencing within an area of interest to identify recognized and novel variants. Illumina's 523-gene panel contains all the probable genes that have the ability to cause malignant tumours to develop. Medical laboratories have introduced the product to diagnose patients suffering from acute myeloid leukaemia. In addition, the efficacy of targeted panels for the identification of malignant tumors improves their clinical usefulness. In 64% of cancer cases, NGS panels are clinically beneficial, according to a report reported in JCO Precision Oncology, 2020 driving the Clinical Oncology Next Generation Sequencing Industry. Whole Genome Sequencing segment is anticipated to grow with the fastest CAGR of 8.3% in the forecast period 2021-2026 owing to the usefulness of this technology to discern and compare normal tissues from tumour tissues, segment growth. Moreover, whole-genome sequencing of cancer patients helps to identify therapies for existing mutations and also helps to target mutations ahead of time. It also helps analyse the prognosis of cancer and establish a treatment regimen depending on the genes affected aiding to the Clinical Oncology Next Generation Sequencing Market growth.

Inquiry Before Buying

Clinical Oncology Next Generation Sequencing Market Segment Analysis - By Application

Based on Application, Clinical Oncology Next Generation Sequencing Market is segmented into Screening - Sporadic Cancer and Inherited Cancer, Companion Diagnostics and Other Diagnostics. Screening accounted for the largest revenue market share in 2020. The most effective way to identify genetic alterations that can be targeted for clinical benefit in cancer patients is currently considered to be NGS-based testing. This technology enables clinicians to analyse several alterations of genes simultaneously. Moreover, as opposed to other pathology methods, technology needs less tumor tissues. An increase in the number of cancer sequencing projects is also increasing the growth of the segment. For instance, 38 different types of cancer were analysed by the Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium by sequencing more than 2,600 tumour samples aiding to the market's growth. Companion Diagnostics segment is anticipated to grow with the fastest CAGR of 9.1% during the forecast period 2021-2026. Efforts taken by key market participants to develop advanced computational tools propel the segment growth. For instance, in January 2021, scientists from the MD Anderson Cancer Center created CopyKAT, a new computational tool to distinguish between normal as well as cancer cells in a tumour thus enhancing the Companion Diagnostics segment demand.

Clinical Oncology Next Generation Sequencing Market Segment Analysis - By Geography

Based on Geography, North America Clinical Oncology Next Generation Sequencing Market accounted for the 36% revenue share in 2020. This rise is accounted for by substantial efforts made by regulatory bodies to boost cancer screening detection in the U.S. For instance, the U.S.-initiated Cancer Genome Atlas programme, Next-generation sequencing has been conducted by the National Cancer Institute (NCI) of more than 20,000 primary cancer samples from 33 different cancer types. A consortium of 12 cancer centres, including Johns Hopkins University, Dana-Farber Cancer Institute, and others throughout the United States, is the NCI's Cancer Aim Discovery and Growth Network enhancing the Clinical Oncology Next Generation Sequencing Market. In January 2020, in the United States, the Intelligence Advanced Research Projects Activity provided $23 million to the Broad Institute and Harvard University, and DNA Script. In addition, the emergence of a range of laboratories, academic institutions and hospitals that provide early cancer detection and treatment services based on NGS is owing to the growth of the regional sector. For instance, EasyDNA Canada, a Toronto-based DNA Biotechnology testing company, provides Cancer Predisposition Panel tests that use NGS technology to recognise mutations in a total of 98 genes associated with 25 inherited cancers. The test helps to recognise people who at a later stage of their lives are at a high risk of developing cancer drive the regional growth. Asia-Pacific is predicted to be the fastest-growing region during the forecast period 2021- 2026 owing to the increasing automation in the pre-sequencing protocols in this particular region thereby aiding to regional growth.

Schedule a Call

Clinical Oncology Next Generation Sequencing Market Drivers

Increasing Prevalence of Cancer:

Cancer is the second leading cause of death worldwide, according to the WHO, and was responsible for an estimated 9.6 million fatalities in 2018. Need for cancer therapies is rising with the increasing number of cancer cases and deaths caused by cancer. Thus government of various economies focus on drug development, targeted sequencing for the reduction of cancer cases have also increased. Rising biomedical research using next-generation clinical oncology sequencing is estimated to create a favourable environment in the near future for the growth of the next-generation clinical oncology sequencing industry. With substantial advances in genetic sequencing and biomedical science, much research into monoclonal antibodies is now focused on discovering new development targets and optimizing their effectiveness for clinical practice, demonstrating a significant effect on the need for the Clinical Oncology Next Generation Sequencing Market.

Decreasing Sequencing Costs Are Highly Likely To Lead To Market Growth:

In clinical oncology, research and academic institutions are generally interested in the characteristic features of next-generation targeted sequencing technology. The next-generation sequencing techniques in clinical oncology give a high percentage of reads and cost-effectiveness per read. The arrival of low-cost sequencing platforms on the market has made this possible. This increases the overall growth of the next-generation sequencing market for clinical oncology. Several industry players, such as Roche and Illumina, have launched sequencing techniques that have reduced the cost of next-generation sequencing for clinical oncology. Government support for life science research is also estimated to result in the availability of funding for the undertaking of different next-generation sequencing projects in clinical oncology, as well as for the jobs of the staff needed which further act as a driving factor for the growth of the Clinical Oncology Industry.

Clinical Oncology Next Generation Sequencing Market Challenges

Major Regulatory Concerns & Lack Skilled Professionals:

Regulatory concerns regarding usage of Clinical Oncology Next Generation Sequencing Analysis and growing stringent government policy and regulation towards the quantity of service being used in application is restraining growth of the market. Market restrain is also owing to the difficulty in the management of large data and complications, associated with Big Data management. In addition, some of the ethical issues associated with whole-genome sequencing, coupled with the lack of awareness among people are constraining the growth of the market. In addition, the lack of skilled professionals with the sequencing that could be serious for diagnosis purpose set to restrain the market growth. It gets difficult when in an emergency situation, the queue of patients have to wait for experts in the required field negatively impacting the growth.

Buy Now

Clinical Oncology Next Generation Sequencing Industry Outlook:

Product launches, mergers and acquisitions, joint ventures and geographical expansions are key strategies adopted by players in the Clinical Oncology Next Generation Sequencing Market. Clinical Oncology Next Generation Sequencing Market top 10 companies are Illumina, Inc., Qiagen N.V., Pacific Biosciences of California, Inc., Takara Bio, Inc., Creative Biolabs, Mogene LC, F. Hoffmann-La Roche Ltd, Oxford Nanopore Technologies, Agilent Technologies and Thermo Fisher Scientific Inc.

Acquisitions/Product Launches:

In January 2021, 4baseCare, a start-up in precision oncology, partnered with the Advanced Centre for Cancer Treatment, Study and Education (ACTREC), India, to develop ClinOme, an AI-driven platform for clinical interpretation

In May 2020, Illumina, Inc., has partnered with Burning Rock Biotech Limited, a cancer test provider based in China, to promote the standardisation and development within China of the selection of NGS-based cancer therapy. The company has also signed an agreement to develop and commercialise myChoice tumour testing in China with Myriad Genetics, Inc.

In March 2019, Oxford Nanopore Technologies launched a new paradigm of smaller, on-demand DNA or RNA sequencing tests with the potential to transform a variety of applications where rapid insights are needed at a low cost.

0 notes

saadkhan2917 · 1 month

Text

Hematology Instruments and Reagents Market 2024 - By Growth Rat, Share, Analysis, Outlook and Forecast To 2034

The Reports Intellect specialized and business intelligence entitled Global Hematology Instruments and Reagents Market (2024-2032) provides an overview of market availability, detailed analysis, competitive composition, and revenue forecasting. The report contains several key features to gaining a vital market assessment. The report likewise offers top players in this market. The research includes in-depth insight into the global size, share, and developments, along with the growth rate of the Hematology Instruments and Reagents Market to evaluate its expansion during the course of the predicted period. The Hematology Instruments and Reagents market report details insights on crucial factors responsible for the growth of the market shareholders and new players.

Key Players covering This Report: - Sysmex Danaher Nihon Kohden Siemens Abbott Laboratories Boule Diagnostics HORIBA Diatron Drew Scientific EKF Diagnostics Mindray Roche

The foremost vendors operating in the market are described based on product range, quality, price, brand, regional presence, and other facets. Detailed analysis of these players, accompanied by their key growth strategies is also covered in this report. Furthermore, strategic development activities of these vendors such as product expansion, partnership/collaboration, and investments among others are discussed in the Hematology Instruments and Reagents market report.

To Understand How Covid-19 Impact Is Covered in This Report Request a Sample Copy @ https://www.reportsintellect.com/sample-request/2910352

Description:

The report focuses on in-depth research on market size, CAGR, company profiles, and trending market dynamics. Our comprehensive report aims to identify markets aspects and significant developments to assess the increasing numbers of challenges, growth aspects, and threats. Moreover, a description of financial terms such as cost, revenue, stocks, and profit margin has been included in this Global Hematology Instruments and Reagents Market document to better comprehend the different economics of the business.

Hematology Instruments and Reagents Market by types: Hematology Instruments Hematology Reagents

Hematology Instruments and Reagents Market by Applications: Stand-Alone Hospitals Commercial Organizations Clinical Testing Labs Research Institutes

Geographical Regions covered by Hematology Instruments and Reagents Market are:

North America Country (United States, Canada) South America Asia Country (China, Japan, India, Korea) Europe Country (Germany, UK, France, Italy) Other Country (Middle East, Africa, GCC)

Get an Exclusive Discount on this report @ https://www.reportsintellect.com/discount-request/2910352

NOTE: The Hematology Instruments and Reagents report has been formulated while considering the COVID-19 Pandemic and its impact on the market.

Customization of the Report:

The given Hematology Instruments and Reagents market research report can also be customized as per the client requirements. The client can reach out to our sales team ([email protected]) who will ensure that you get the report as per your requirements and needs.

Why us:

We facilitate you with a crucial detailed insight report on the Hematology Instruments and Reagents market.

Descriptive graphs, explanatory charts, and more analytical tools to provide the clients with more factual data in very effective yet simple to grasp illustrations.

We provide you with a report that educates you on the challenges and issues of the Hematology Instruments and Reagents market and provides you with data needed to overcome those issues and maximize your growth potential.

Some Key Questions answered in this Report are:

· What is the current Hematology Instruments and Reagents market scope in the global landscape?

· What are the opportunities to focus and grow in the Hematology Instruments and Reagents Market?

· What are the most suitable business segments to ensure maximum profitability in Hematology Instruments and Reagents market?

About Us: Reports Intellect is your one-stop solution for everything related to market research and market intelligence. We understand the importance of market intelligence and its need in today's competitive world. Our professional team works hard to fetch the most authentic research reports backed with impeccable data figures which guarantee outstanding results every time for you. So whether it is the latest report from the researchers or a custom requirement, our team is here to help you in the best possible way. Contact Us: [email protected] Phone No: + 1-706-996-2486 US Address: 225 Peachtree Street NE, Suite 400, Atlanta, GA 30303

0 notes

healthcaremarketanalysis · 2 months

Text

Point of Care Diagnostics Market worth $77.8 billion by 2028

The global point-of-care diagnostics market, valued at $49.7 billion in 2023, is projected to reach $77.8 billion by 2028, growing at a CAGR of 9.4%. Key drivers include the rising prevalence of infectious diseases like influenza, HIV, and tuberculosis, supportive government policies, and the shift towards healthcare decentralization. Challenges include pricing pressures due to reimbursement cuts and stringent regulatory approvals. Significant growth opportunities exist in emerging markets like China, India, Brazil, and Mexico. In 2022, glucose monitoring products held a significant market share, with lateral flow assays leading by platform. Major players include Abbott Laboratories, F. Hoffman-La Roche Ltd., BD, Danaher Corporation, and Siemens Healthineers. Recent developments feature FDA approvals for new diagnostic panels by bioMérieux and BD, and a partnership between Thermo Fisher Scientific and Project HOPE to expand HIV testing in Sub-Saharan Africa.

Download an Illustrative overview:

Browse in-depth TOC on "Point of Care Diagnostics Market"

191 - Tables

51 - Figures

322 – Pages

The Lateral Flow Assays segment, by platform, is expected to register the largest market share of the global point of care diagnostics industry in 2022.

Based on platform, the point-of-care diagnostics market is segmented into lateral flow assays, immunoassays, microfluidics, dipsticks, and molecular diagnostics. The lateral flow assays segment dominated this market with a share of in 2022.Lateral flow assays are simple in usage, relatively inexpensive, making it more accessible for patients and healthcare provider, LFA technology does not require trained person to operate, allowing them to be used in various healthcare settings, from clinics and pharmacies to remote arears, promoting healthcare decentralization. All these factors are contributing towards the dominance of lateral flow technology in point of care diagnostics market.

The OTC testing product segment, by mode of purchase, to dominate the global point of care diagnostics industry in 2022.

On the basis of mode of purchase OTC testing products segment accounted the largest market share in 2022 attributed to the increasing adoption of OTC products owing to its ease of usage and convenience. The presence of diverse range of OTC point of care devices for diseases screening, personal health monitoring and various other conditions further contribute to the rising demand for OTC PoC testing devices among consumers.

North America to account for the largest share of point of care diagnostics industry during the forecast period.

North America is the expected to be the largest regional market for point of care diagnostics during the forecast period. The presence of a well-established healthcare system, rapid adoption of advanced point of care testing products, increase in the availability of medical reimbursement, favourable government support for the novel product development, and higher user awareness about the presence of point of care testing products are anticipated to support the market growth in the region

Request Sample Pages:

Point of Care Diagnostics Market Dynamics:

Drivers:

Rising incidence of infectious diseases

Increasing prevalence of target conditions

Favorable government initiatives for POC testing

Rising number of CLIA-waived POC tests

Restraints:

Pricing pressure on POC manufacturers

Stringent regulatory approval process for product commercialization

Opportunities:

High growth potential of emerging markets

Decentralization of healthcare

Innovative product development

Challenge:

Inadequate standardization with centralized lab methods

Limited awareness in emerging markets

Premium pricing of novel platforms

Key Market Players of Point of Care Diagnostics Industry:

As of 2022, the point of care diagnostics market was dominated by Abbott Laboratories (US), F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), and Becton, Dickinson and Company (US)

Point of Care Diagnostics Market - Key Benefits of Buying the Report:

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

Analysis of Key divers (rising prevalence of infectious and chronic disease, growing adoption of self-testing kits, helathacre decentralization, rising number of CLIA-wavier Poc Tests), restraints (rising pricing pressure on PoC manufactures, stringent regulatory approval procedures for new PoC devices), Opportunities (emerging markets, emerging technologies, such s microfluidics) , Challenge (Training & education in low resource countries)

Market Penetration: Comprehensive information on the product portfolios offered by the top players in the point-of-care diagnostics market

Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the point-of-care diagnostics market

Market Development: Comprehensive information on lucrative emerging regions

Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the point-of-care diagnostics market

Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.